Anuh Pharma Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Anuh Pharma Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Profit Cash Ratio: Over the last 3 years, every ₹100 of reported profit came with ₹32 of operating cash. Lower than 86% of Healthcare companies in India.
- Cash Cushion Ratio: Cash, after subtracting all debt, equals 7% of its market value (net cash). Higher than 86% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹32Over the last 3 years, every ₹100 of reported profit came with ₹32 of operating cash.
Lower than 86% of Healthcare companies in India.
Self-Funding Ratio
1.4×Over the last 3 years its own operating cash covered its investment spending (capex) 1.4 times.
Higher than 54% of Healthcare companies in India.
Cash Locked Ratio
₹24For every ₹100 of sales, ₹24 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹16 tied up three years earlier.
More money tied up than 51% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Less steady than 68% of Healthcare companies in India.
Growth Efficiency Ratio
₹2Sales grew 46% in 3 years; of every extra ₹100 of sales, ₹2 became extra profit.
Lower than 83% of Healthcare companies in India.
Asset Productivity Ratio
+46% / +38%In 3 years sales changed by +46% while total assets changed by +38%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
No debt dueNo debt falls due within a year, according to the latest yearly balance sheet.
Cash Cushion Ratio
+7%Cash, after subtracting all debt, equals 7% of its market value (net cash).
Higher than 86% of Healthcare companies in India.
Tangible Assets Ratio
100%Of every ₹100 the company owns, ₹100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 84% of Healthcare companies in India.
Tangible Net Worth Ratio
100%Of every ₹100 of net worth, ₹100 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 81% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Anuh Pharma Limited owes ₹0.37 for every ₹1 it owns. Net profit fell 13% in the year to Mar 2026, and grew 4% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
17.9Investors pay ₹17.9 for every ₹1 of Anuh Pharma Limited's yearly profit, lower than 87% of Healthcare companies in India.
P/B ratio
2.24The share price is 2.24 times Anuh Pharma Limited's book value per share, lower than 82% of Healthcare companies in India.
Market cap
₹790 CrThe total market value of all of Anuh Pharma Limited's shares at today's price (share price × number of shares), smaller than 83% of Healthcare companies in India. PosiCap size class: Micro Cap.
Net worth (book value)
₹352 CrWhat Anuh Pharma Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹35.14Net worth divided by the number of shares. The share price of ₹78.87 is 2.2 times this, which is the P/B above.
Return on equity (ROE)
12.6%Anuh Pharma Limited earned 12.6% on its shareholders' money over the last year, lower than 51% of Healthcare companies in India.
Owes vs Owns
0.37×Anuh Pharma Limited owes ₹0.37 for every ₹1 it owns (low), lower than 51% of Healthcare companies in India.
Dividend yield
1.83%Anuh Pharma Limited pays 1.83% of its share price as dividends a year, higher than 89% of dividend-paying Healthcare companies in India.
Revenue growth
+17%Revenue rose 17% in the year to Mar 2026, and grew 14% a year on average over 3 years.
Profit growth
-13%Net profit fell 13% in the year to Mar 2026, and grew 4% a year on average over 3 years.
Profit margin
5.3%Anuh Pharma Limited keeps ₹5 of every ₹100 of revenue as net profit.
Cash quality
-0.1×Cash from Anuh Pharma Limited's business was -0.1× its reported profit in the year to Mar 2026 — the business used cash even though it reported a profit.
Interest cover
120.6×Anuh Pharma Limited's operating profit covered its interest costs 120.6 times in the year to Mar 2026.
Cash vs debt
Net cashAnuh Pharma Limited held ₹53 Cr more cash than debt (net cash) at Mar 2026.
Questions
What is Anuh Pharma Limited's P/E ratio?
Investors pay ₹17.9 for every ₹1 of Anuh Pharma Limited's yearly profit, lower than 87% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Anuh Pharma Limited: ₹790 Cr ÷ ₹352 Cr (31 Mar 2026) = 2.2.
What is Anuh Pharma Limited's return on equity?
Anuh Pharma Limited earned 12.6% on its shareholders' money over the last year, lower than 51% of Healthcare companies in India.
How much does Anuh Pharma Limited owe compared with what it owns?
Anuh Pharma Limited owes ₹0.37 for every ₹1 it owns (low), lower than 51% of Healthcare companies in India.
Does Anuh Pharma Limited pay a dividend?
Yes. Anuh Pharma Limited pays 1.83% of its share price as dividends a year, higher than 89% of dividend-paying Healthcare companies in India.
Is Anuh Pharma Limited's revenue growing?
Revenue rose 17% in the year to Mar 2026, and grew 14% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.